Mast cell activation by fibrinogen-related homologous c-terminal peptides (haptides) modulates systemic blood pressure

Journal of Allergy and Clinical Immunology

Volumn 126, Issue 5, 2010, Pages 1041-1048

  Basheer, Maamoun ^a   Schwalb, Herzl ^b   Nesher, Maoz ^b   Gilon, Dan ^b   Shefler, Irit ^c   Mekori, Yoseph A ^c   Shapira, Oz M ^b   Gorodetsky, Raphael ^a  

^a Sharett Institute of Oncology   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c MEIR MEDICAL CENTER   (Israel)

Author keywords

Fibrin; Haptides; Histamine; Hypotension; Mast cells; Serotonin

Indexed keywords

ANTIHISTAMINIC AGENT; FIBRINOGEN; HAPTIDE; HISTAMINE; PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANAPHYLACTIC SHOCK; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARBOXY TERMINAL SEQUENCE; CELL ACTIVATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; FIBRINOLYSIS; HISTAMINE RELEASE; HUMAN; HUMAN CELL; HYPOTENSION; MALE; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERITONEUM MAST CELL; PRIORITY JOURNAL; RAT; SHOCK; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ANTIGENS; BLOOD PRESSURE; CELL DEGRANULATION; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; MAST CELLS; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 78049459829     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.07.020     Document Type: Article

References (49)

1. R. Gorodetsky, A. Vexler, J. An, X. Mou, and G. Marx Haptotactic and growth stimulatory effects of fibrin(ogen) and thrombin on cultured fibroblasts J Lab Clin Med 131 1998 269 280
2. R. Gorodetsky, A. Vexler, M. Shamir, J. An, L. Levdansky, and I. Shimeliovich New cell attachment peptide sequences from conserved epitopes in the carboxy termini of fibrinogen Exp Cell Res 287 2003 116 129
3. M.W. Mosesson Fibrinogen and fibrin structure and functions J Thromb Haemost 3 2005 1894 1904
4. Y. Fu, Y. Cao, K.M. Hertzberg, and G. Grieninger Fibrinogen alpha genes: conservation of bipartite transcripts and carboxy-terminal-extended alpha subunits in vertebrates Genomics 30 1995 71 76
5. R. Gorodetsky, L. Levdansky, A. Vexler, I. Shimeliovich, I. Kassis, and M. Ben-Moshe Liposome transduction into cells enhanced by haptotactic peptides (haptides) homologous to fibrinogen C-termini J Control Release 95 2004 477 488
6. G. Marx, A. Hotovely-Salomon, L. Levdansky, E. Gaberman, G. Snir, and Z. Sievner Haptide-coated collagen sponge as a bioactive matrix for tissue regeneration J Biomed Mater Res B Appl Biomater 84 2008 571 583
7. M. Basheer, H. Schwalb, D. Gilon, V. Doviner, Y. Sherman, and O.M. Shapira Short homologous peptides based on C-terminal sequences of fibrinogen beta- and gamma-chains (haptides) affect cardiovascular function by eNOS inhibition J Vasc Res 47 2010 507 518
8. J.B. Walker, and M.E. Nesheim The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin J Biol Chem 274 1999 5201 5212
9. M.A. Lucas, L.J. Fretto, and P.A. McKee The relationship of fibrinogen structure to plasminogen activation and plasmin activity during fibrinolysis Ann N Y Acad Sci 408 1983 71 91
10. P.A. Nee Thrombolysis after acute myocardial infarction J Accid Emerg Med 14 1997 2 9
11. D. Glogar, P. Yang, and G. Steurer Management of acute myocardial infarction: evaluating the past, practicing in the present, elaborating the future Am Heart J 132 2 pt 2 suppl 1996 465 470 discussion 496-502
12. V. Menon, R.A. Harrington, J.S. Hochman, C.P. Cannon, S.D. Goodman, and R.G. Wilcox Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 3 suppl 2004 549S 575S
13. V.J. Marder, N.R. Shulman, and W.R. Carroll High molecular weight derivatives of human fibrinogen produced by plasmin, I: physicochemical and immunological characterization J Biol Chem 244 1969 2111 2119
14. P.S. Wells, D.R. Anderson, M. Rodger, M. Forgie, C. Kearon, and J. Dreyer Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis N Engl J Med 349 2003 1227 1235
15. T. Baglin Disseminated intravascular coagulation: diagnosis and treatment BMJ 312 1996 683 687
16. P.J. Gaffney, M. Brasher, K. Lord, C.J. Strachan, A.R. Wilkinson, and V.V. Kakkar Fibrin subunits in venous and arterial thromboembolism Cardiovasc Res 10 1976 421 426
17. G.D. Lowe, J.W. Yarnell, A. Rumley, D. Bainton, and P.M. Sweetnam C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis? Arterioscler Thromb Vasc Biol 21 2001 603 610
18. J.J. Michiels, G. Palareti, and P. de Moerloose Fibrin D-dimer testing for venous and arterial thrombotic disease Semin Vasc Med 5 2005 311 314
19. J.P. McRedmond, P. Harriott, B. Walker, and D.J. Fitzgerald Streptokinase-induced platelet activation involves antistreptokinase antibodies and cleavage of protease-activated receptor-1 Blood 95 2000 1301 1308
20. D.G. Chalupowicz, Z.A. Chowdhury, T.L. Bach, C. Barsigian, and J. Martinez Fibrin II induces endothelial cell capillary tube formation J Cell Biol 130 1995 207 215
21. L.A. Sporn, L.A. Bunce, and C.W. Francis Cell proliferation on fibrin: modulation by fibrinopeptide cleavage Blood 86 1995 1802 1810
22. J.A. Ribes, F. Ni, D.D. Wagner, and C.W. Francis Mediation of fibrin-induced release of von Willebrand factor from cultured endothelial cells by the fibrin beta chain J Clin Invest 84 1989 435 442
23. C.W. Francis, L.A. Bunce, and L.A. Sporn Endothelial cell responses to fibrin mediated by FPB cleavage and the amino terminus of the beta chain Blood Cells 19 1993 291 306
24. M. Aridor, L.M. Traub, and R. Sagi-Eisenberg Exocytosis in mast cells by basic secretagogues: evidence for direct activation of GTP-binding proteins J Cell Biol 111 1990 909 917
25. P.A. Shore, A. Burkhalter, and V.H. Cohn Jr. A method for the fluorometric assay of histamine in tissues J Pharmacol Exp Ther 127 1959 182 186
26. A.S. Kirshenbaum, C. Akin, Y. Wu, M. Rottem, J.P. Goff, and M.A. Beaven Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI Leuk Res 27 2003 677 682
27. M. Shalita-Chesner, R. Koren, Y.A. Mekori, D. Baram, C. Rotem, and U.A. Liberman 1,25-Dihydroxyvitamin D3 enhances degranulation of mast cells Mol Cell Endocrinol 142 1998 49 55
28. S.P. Bhattacharyya, I. Drucker, T. Reshef, A.S. Kirshenbaum, D.D. Metcalfe, and Y.A. Mekori Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact J Leukoc Biol 63 1998 337 341
29. M. Kulka, C.H. Sheen, B.P. Tancowny, L.C. Grammer, and R.P. Schleimer Neuropeptides activate human mast cell degranulation and chemokine production Immunology 123 2008 398 410
30. P. Salamon, N.G. Shoham, I. Puxeddu, Y. Paitan, F. Levi-Schaffer, and Y.A. Mekori Human mast cells release oncostatin M on contact with activated T cells: possible biologic relevance J Allergy Clin Immunol 121 2008 448 455 e5
31. I.H. Page, and C.J. Mc Modification of vascular response to serotonin by drugs Am J Physiol 174 1953 436 444
32. P.R. Saxena, and C.M. Villalon Cardiovascular effects of serotonin agonists and antagonists J Cardiovasc Pharmacol 15 suppl 7 1990 S17 S34
33. C.M. Villalon, J.P. Heiligers, D. Centurion, P. De Vries, and P.R. Saxena Characterization of putative 5-HT7 receptors mediating tachycardia in the cat Br J Pharmacol 121 1997 1187 1195
34. C.M. Villalon, D. Centurion, M. Lujan-Estrada, J.A. Terron, and A. Sanchez-Lopez Mediation of 5-HT-induced external carotid vasodilatation in GR 127935-pretreated vagosympathectomized dogs by the putative 5-HT7 receptor Br J Pharmacol 120 1997 1319 1327
35. R. Pounder Histamine H2-receptor antagonists Baillieres Clin Gastroenterol 2 1988 593 608
36. P. Devillier, N. Roche, and C. Faisy Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine: a comparative review Clin Pharmacokinet 47 2008 217 230
37. G.R. Martin Vascular receptors for 5-hydroxytryptamine: distribution, function and classification Pharmacol Ther 62 1994 283 324
38. D. Hoyer, D.E. Clarke, J.R. Fozard, P.R. Hartig, G.R. Martin, and E.J. Mylecharane International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin) Pharmacol Rev 46 1994 157 203
39. C.M. Villalon, and D. Centurion Cardiovascular responses produced by 5-hydroxytriptamine: a pharmacological update on the receptors/mechanisms involved and therapeutic implications Naunyn Schmiedebergs Arch Pharmacol 376 2007 45 63
40. G. Altiay, A. Ciftci, M. Demir, Z. Kocak, N. Sut, and E. Tabakoglu High plasma D-dimer level is associated with decreased survival in patients with lung cancer Clin Oncol (R Coll Radiol) 19 2007 494 498
41. L.W. Tick, M. Nijkeuter, M.H. Kramer, M.M. Hovens, H.R. Buller, and F.W. Leebeek High D-dimer levels increase the likelihood of pulmonary embolism J Intern Med 264 2008 195 200
42. E. Wojtecka-Lukasik, and S. Maslinski Fibronectin and fibrinogen degradation products stimulate PMN-leukocyte and mast cell degranulation J Physiol Pharmacol 43 1992 173 181
43. H.C. Bankl, and P. Valent Mast cells, thrombosis, and fibrinolysis: the emerging concept Thromb Res 105 2002 359 365
44. L.B. Schwartz, T.R. Bradford, B.H. Littman, and B.U. Wintroub The fibrinogenolytic activity of purified tryptase from human lung mast cells J Immunol 135 1985 2762 2767
45. A.S. Lew, P. Laramee, B. Cercek, P.K. Shah, and W. Ganz The hypotensive effect of intravenous streptokinase in patients with acute myocardial infarction Circulation 72 1985 1321 1326
46. A. Pachai, A.K. Erlendsson, and I. Brandslund Streptokinase, complement activation and hypotension APMIS 105 1997 650 654
47. J.D. Gemmill, K.J. Hogg, J.T. Douglas, F.G. Dunn, G.D. Lowe, and A.P. Rae The incidence and mechanism of hypotension following thrombolytic therapy for acute myocardial infarction with streptokinase-containing agents - lack of relationship to pretreatment streptokinase resistance Eur Heart J 14 1993 819 825
48. F.E. Simons Anaphylaxis J Allergy Clin Immunol 121 suppl 2 2008 S402 S407
49. T. Oki, J. Kitaura, K. Eto, Y. Lu, M. Maeda-Yamamoto, and N. Inagaki Integrin alphaIIbbeta3 induces the adhesion and activation of mast cells through interaction with fibrinogen J Immunol 176 2006 52 60